Pharmaceutisch Weekblad

, Volume 12, Issue 1, pp 19–22 | Cite as

Intramural and extramural health care in the United Kingdom

  • Peter R. Noyce
The Initiating Role of Hospital Pharmacy


In this article the factors which determine whether health care in the United Kingdom is provided in hospital, at home or through intermediate or shared care arrangements are considered. The following aspects of home health care in the United Kingdom are discussed:
  • continuous ambulatory peritoneal dialysis;

  • parenteral nutrition;

  • cytotoxic therapy;

  • terminal care/pain control;

  • intravenous antibiotics;

Pharmaceutical implications of the transfer of the long-term care of the mentally ill, mentally handicapped and elderly from hospital to community settings are also considered. Key changes in the development of pharmacy in the United Kingdom are mentioned and the emergence of a new group, community service pharmacists, is identified.


Drug utilization Home care services Infusions, parenteral Patient education Peritoneal dialysis, continuous ambulatory Pharmacy service, hospital Terminal care 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Coles GA. Is peritoneal dialysis a good long-term treatment? Br Med J 1985;290:1164–6.Google Scholar
  2. 2.
    Heaton A, Rodger RSC, Sellars L, et al. Continuous ambulatory peritoneal dialysis after the honeymoon review of experience in Newcastle: 1979–1984. Br Med J 1986;293:938–41.Google Scholar
  3. 3.
    Morgan AG, Burden RP. Effect of continuous ambulatory peritoneal dialysis on a British renal unit. Br Med J 1986;293:935–7.Google Scholar
  4. 4.
    Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986;3:383–6.Google Scholar
  5. 5.
    Malone M. Home health care in the USA. Pharm J 1988;241:539.Google Scholar
  6. 6.
    Lennard-Jones JE, Wood S. The organisation of intravenous feeding at home. Health Trends 1985;17:73–4.Google Scholar
  7. 7.
    O'Connor M, Malone M, Hambleton R. J Clin Pharm Ther 1988;13:403–9.Google Scholar
  8. 8.
    Thomas M. Miniaturised continuous delivery systems for injectable solutions — individual patient control and physico-chemical properties. Proc Guild Hosp Pharm 1985;19:3–37.Google Scholar
  9. 9.
    Rowland CG. Home continuous infusion chemotherapy. Practitioner 1985;229:889–92.Google Scholar
  10. 10.
    Sewell G, Bradford E, Rowland CG. HOPE for cancer. J Distr Nurs 1987;(April):4/6.Google Scholar
  11. 11.
    Adams PS, Haines-Nutt RF, Bradford E, Palmer A. Domiciliary treatment of cancer patients using continuous infusion therapy. Proc Guild Hosp Pharm 1987;24:77–80.Google Scholar
  12. 12.
    Dover S. Advances in the use of opioids for domiciliary terminal care. Practitioner 1988;232:884–6.Google Scholar
  13. 13.
    Nicholson H. The success of the syringe driver. Nursing Times 1986;(July 9):49–51.Google Scholar
  14. 14.
    Allwood MC. Diamorphine mixed with anti-emetic drugs in plastic syringes Br J Pharm Pract 1984;6:88–90.Google Scholar
  15. 15.
    Chamberlain TM, Lehman ME, Groh MJ, Munroe WP, Reinden TP. Am J Hosp Pharm 1988;45:2341–5.Google Scholar
  16. 16.
    Catchpole A. Cystic fibrosis. Intravenous treatment at home. Nursing Times 1988;85(12):40–2.Google Scholar
  17. 17.
    Gilbert J, Robinson T. Littlewood JM. Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child 1988;63:512–7.Google Scholar
  18. 18.
    Royal College of Physicians. Medication for the elderly. J R Coll Phys Lond 1984;18(1):3–10.Google Scholar
  19. 19.
    Iles V, Noyce PR. Medicines in residential homes. Pharmacy Update 1987;3:117–23.Google Scholar
  20. 20.
    Rivers PH, Poston JW, Cullen AMS. Pharmaceutical care in social services residential homes and hostels. J Soc Admin Pharm 1986;4:23–9.Google Scholar
  21. 21.
    Pharmaceutical Society. The administration and control of medicines in residential homes. London: Pharmaceutical Society of Great Britain, 1986.Google Scholar
  22. 22.
    Committee of Inquiry. Pharmacy. A report to the Nuffield Foundation. London: The Nuffield Foundation, 1986.Google Scholar
  23. 23.
    Baker JA, Lant AF, Sutters CA. Seventeen years' experience of a voluntarily based drug rationalisation programme in hospital. Br Med J 1988;297:465–9.Google Scholar
  24. 24.
    Department of Health. Health Services Management. The way forward for hospital pharmaceutical services. London: Department of Health, 1988:HC(88)54.Google Scholar
  25. 25.
    Department of Health & Social Security. Promoting better health — the Government's programme for improving primary health care. London: Her Majesty's Stationery Office, 1987;Cmnd 249:35–9.Google Scholar
  26. 26.
    Department of Health. Working for patients. London: Her Majesty's Stationery Office, 1989:Cmnd 555.Google Scholar
  27. 27.
    Taylor B, Barber L. Developing role of the community health service pharmacist. Pharm J 1986;236:276–7.Google Scholar
  28. 28.
    Barber L, Taylor B. Community services pharmacy — a developing role. Br J Pharm Pract 1988;10:368–71.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1990

Authors and Affiliations

  • Peter R. Noyce
    • 1
  1. 1.Pharmaceutical Division, Department of HealthLondonUK

Personalised recommendations